- Graduate School - Northwestern University Feinberg School of Medicine (2010-2011)
- Other Post Graduate Training - Northwestern University Graduate School (2010-2011)
- Medical School - University of Virginia School of Medicine (1999-2007)
- Residency - McGaw Medical Center of Northwestern University (2007-2010), Internal Medicine
- Fellowship - Northwestern University Feinberg School of Medicine (2011-2014), Gastroenterology
- Fellowship - Northwestern University Feinberg School of Medicine (2014-2015), Transplant Hepatology
Lisa VanWagner, M.D.
Director of Clinical Research, Division of Digestive and Liver Diseases
- Internal Medicine - Digestive and Liver Diseases
- Liver Transplantation
- Nonalcoholic fatty liver disease (NAFLD)
New Patient Appointment Accepting Virtual Visits or 214-645-0595
Biography
Lisa VanWagner, M.D., M.Sc., is an Associate Professor in the Department of Internal Medicine at UT Southwestern Medical Center. She specializes in liver transplantation medicine, fatty liver disease, and cardiac cirrhosis.
Dr. VanWagner earned her medical degree at the University of Virginia School of Medicine in Charlottesville. She completed a residency in internal medicine at Northwestern University's McGaw Medical Center in Chicago, where she served as Chief Resident and obtained a master's degree in clinical investigation. She remained at Northwestern to gain advanced training through a fellowship in gastroenterology and hepatology, followed by an advanced fellowship program in transplant hepatology. She also completed a postdoctoral fellowship in big data and cardiovascular risk prediction at Northwestern.
Certified by the American Board of Internal Medicine in internal medicine, gastroenterology and hepatology, and transplant hepatology, she joined the UT Southwestern faculty in 2022. Previously, she served as an Assistant Professor of Medicine at Northwestern University's Feinberg School of Medicine.
At UT Southwestern, Dr. VanWagner’s clinical practice focuses on nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH), a condition associated with high cardiovascular risk; patients with liver disease due to congenital heart disease or heart failure; and patients undergoing heart-liver transplantation.
She also serves as Director of Clinical Research for the Division of Digestive and Liver Diseases. Her clinical research laboratory utilizes human population-based approaches, large electronic health record data analysis, and health services research methods to define and characterize cardiometabolic disease risk prediction, prevention, and treatment approaches in patients with chronic liver disease.
Dr. VanWagner's scientific work has garnered awards from the American Association for the Study of Liver Diseases, the European Association for the Study of the Liver, the American Society of Transplantation, and the American Heart Association. She has published more than 100 peer-reviewed manuscripts and has received National Institutes of Health, foundation, and industry funding to support her research. She is an Associate Editor of Liver Transplantation and sits on the editorial board of Gastroenterology and Hepatology Communications; she also serves as an ad hoc reviewer for numerous other scholarly journals.
A Fellow of the American Heart Association and the American Society of Transplantation, Dr. VanWagner is also an active member of the American Association for the Study of Liver Diseases, the American Gastroenterological Association, the European Association for the Study of the Liver, and the International Liver Transplantation Society.
Personal Note
During her free time, Dr. VanWagner enjoys cooking, traveling, and spending time with her family.
Education & Training
Professional Associations & Affiliations
- American Association for the Study of Liver Diseases
- American Gastroenterological Association
- American Society of Transplantation
- American Heart Association
- European Association for the Study of the Liver
- International Liver Transplantation Society
Honors & Awards
- Midcareer Transition Grant Award 2022, American Society of Transplantation
- Outstanding Article Award in Clinical Transplantation 2021, American Journal of Transplantation
- Young Physician-Scientist Award 2021, American Society for Clinical Investigation
- Fellow 2018, American Society of Transplantation
- Fellow 2018, American Heart Association
- Faculty Teaching Award 2017, Northwestern University
- Feinberg Academy of Medical Educators 2017, Northwestern University
- Finalist for the Sandra Daugherty Award for Excellence in Cardiovascular Disease Epidemiology 2017, American Heart Association
Books & Publications
-
Books
-
Should Liver Biopsy Be Performed in All Patients With Nonalcoholic Fatty Liver Disease in Controversies in Hepatology: The Experts Analyze Both Sides
Parikh N, VanWagner LB, Rinella ME (2011), Slack Incorporated -
Viral Hepatitis in solid organ transplant recipients in Viral Hepatitis-Selected Issues of Pathogenesis and Diagnostics
VanWagner LB, Levitsky J (2011), Tech Publisher -
Other viruses that affect the liver in Viral Hepatitis, Clinical Care Options Hepatology in Practice
VanWagner LB, Levitsky J (2011) -
The Patient with Pre-Operative Evaluation Electrocardiogram (ECG) in The Electrocardiogram in Clinical Medicine: Applications in the Acute, Critical, and Emergency Care Settings
Chuzi S, Wilcox JE, VanWagner LB (2017)
-
Should Liver Biopsy Be Performed in All Patients With Nonalcoholic Fatty Liver Disease in Controversies in Hepatology: The Experts Analyze Both Sides
-
Publications
-
Radiological and Surgical Treatments of Portal Hypertension.
Hunt C, Patel M, Bayona Molano MDP, Patel MS, VanWagner LB, Clinics in liver disease 2024 Aug 28 3 437-453 -
Psychiatric diagnoses are common after liver transplantation and associated with increased healthcare utilization and patient financial burden.
Lieber SR, Jones AR, Jiang Y, Gowda P, Patel M, Lippe B, Shenoy A, Evon DM, Gurley T, Ngo V, Olumesi M, Trudeau RE, Noriega Ramirez A, Jordan-Genco L, Mufti A, Lee SC, Singal AG, VanWagner LB, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2024 May -
Management of the high cardiac risk liver transplant candidate: multidisciplinary best practices and recommendations.
Pagano G, Koshy AN, Chadha R, VanWagner LB, Crespo G, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2024 May -
Association of Disproportionate Liver Fat with Markers of Heart Failure: The Multi-Ethnic Study of Atherosclerosis.
Kusner J, Patel RB, Hu M, Bertoni AG, Michos ED, Pandey AP, VanWagner LB, Shah S, Fudim M, American heart journal 2024 May -
Non-alcoholic fatty liver modifies associations of body mass index and waist circumference with cardiometabolic risk: The CARDIA study.
Mathew M, Pope ZC, Schreiner PJ, Jacobs DR, VanWagner LB, Terry JG, Pereira MA, Obesity science & practice 2024 Apr 10 2 e751 -
Acute kidney injury in patients with Cirrhosis: Acute disease quality Initiative (ADQI) and international Club of ascites (ICA) joint multidisciplinary consensus meeting.
Nadim MK, Kellum JA, Forni L, Francoz C, Asrani SK, Ostermann M, Allegretti AS, Neyra JA, Olson JC, Piano S, VanWagner LB, Verna EC, Akcan-Arikan A, Angeli P, Belcher JM, Biggins SW, Deep A, Garcia-Tsao G, Genyk YS, Gines P, Kamath PS, Kane-Gill SL, Kaushik M, Lumlertgul N, Macedo E, Maiwall R, Marciano S, Pichler RH, Ronco C, Tandon P, Velez JQ, Mehta RL, Durand F, Journal of hepatology 2024 Mar -
Summary of a Consensus Conference on Heart-Liver Transplantation.
Kobashigawa J, VanWagner LB, Hall S, Emamaullee J, Entwistle JW, Ganger D, Gebel H, Jeevanandam V, Kaldas F, Kilic A, Kittleson M, Kushwaha S, Kwong A, Lui GK, Motayagheni N, Patel J, Patel N, Pereira N, Potter L, Sani M, Schiano TD, Shingina A, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2023 Dec -
Aerobic and Muscle-Strengthening Physical Activity, Television Viewing, and Nonalcoholic Fatty Liver Disease: The CARDIA Study.
McDonough DJ, Mathew M, Pope ZC, Schreiner PJ, Jacobs DR, VanWagner LB, Carr JJ, Terry JG, Gabriel KP, Reis JP, Pereira MA, Journal of clinical medicine 2023 Aug 12 17 -
Prognostic value of Coronary artery calcium score for the prediction of atherosclerotic cardiovascular disease in participants with suspected nonalcoholic hepatic steatosis: Results from the Multi-Ethnic Study of Atherosclerosis.
Ichikawa K, Hansen S, Manubolu VS, Pourafkari L, Fazlalizadeh H, Aldana-Bitar J, VanWagner LB, Krishnan S, Budoff MJ, American heart journal 2023 Jul -
The impact of right atrial pressure on outcomes in patients undergoing TIPS, an ALTA group study.
Bommena S, Mahmud N, Boike JR, Thornburg BG, Kolli KP, Lai JC, German M, Morelli G, Spengler E, Said A, Desai AP, Junna S, Paul S, Frenette C, Verna EC, Goel A, Gregory D, Padilla C, VanWagner LB, Fallon MB, Hepatology (Baltimore, Md.) 2023 Jun 77 6 2041-2051 -
The association between hepatic steatosis and incident cardiovascular disease, cancer, and all-cause mortality in a US multicohort study.
Ahmed HS, Wang N, Carr JJ, Ding J, Terry JG, VanWagner LB, Hou L, Huo Y, Palmisano J, Zheng Y, Benjamin EJ, Long MT, Hepatology (Baltimore, Md.) 2023 Jun 77 6 2063-2072 -
Evolution of pretransplant cardiac risk factor burden and major adverse cardiovascular events in liver transplant recipients over time.
Harrington CR, Levy P, Cabrera E, Gao J, Gregory DL, Padilla C, Crespo G, VanWagner LB, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2023 Jun 29 6 581-590 -
Drug-eluting stent use with abbreviated dual antiplatelet therapy after percutaneous coronary intervention for liver transplantation evaluation.
Koshy AN, Sampaio Rodrigues T, Gow PJ, Cailes B, VanWagner LB, Farouque O, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2023 Apr 29 4 459-462 -
More than a few good women: honoring the ladies of the liver.
VanWagner LB, McElroy L, Serper M, Verna EC, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2023 Mar 29 3 237-240 -
Geographic Variation in NAFLD Prevalence and Subspecialty Care Utilization Among Insured Adults in the United States.
Gedallovich SM, Stephen J, Kang R, Ackermann RT, Ladner DP, VanWagner LB, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2023 Jan -
Diagnosis and Management of Hereditary Hemochromatosis.
Cabrera E, Crespo G, VanWagner LB, JAMA 2022 Nov 328 18 1862-1863 -
Factors associated with cardiovascular events after simultaneous liver-kidney transplant from the US Multicenter Simultaneous Liver-Kidney Transplant Consortium.
Jo J, Crespo G, Gregory D, Sinha J, Xie J, Zhang M, Magee J, Barman P, Patel YA, Schluger A, Walters K, Biggins S, Filipek N, Cullaro G, Wong R, Lai JC, Perreault GJ, Verna EC, Sharma P, VanWagner LB, Hepatology communications 2022 Oct -
Emerging Evidence on Coronary Heart Disease Screening in Kidney and Liver Transplantation Candidates: A Scientific Statement From the American Heart Association.
Cheng XS, VanWagner LB, Costa SP, Axelrod DA, Bangalore S, Norman SP, A Herzog C, Lentine KL, Circulation 2022 Oct -
Multicenter Assessment of Hypertension Management of Liver Transplant Recipients.
Chebrolu S, Phipps M, Yao F, Lai J, Verna E, Serper M, Cullaro G, Asrani SK, VanWagner LB, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2022 Jul -
Blood Pressure Variability Early After Liver Transplantation Predicts Long-Term Mortality.
Truitt K, Chen K, Yano Y, Gregory DL, VanWagner LB, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2022 04 28 4 615-622 -
Management of cardiac diseases in liver transplant recipients: Comprehensive review and multidisciplinary practice-based recommendations.
Izzy M, Fortune BE, Serper M, Bhave N, deLemos A, Gallegos-Orozco JF, Guerrero-Miranda C, Hall S, Harinstein ME, Karas MG, Kriss M, Lim N, Palardy M, Sawinski D, Schonfeld E, Seetharam A, Sharma P, Tallaj J, Dadhania DM, VanWagner LB, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2022 Mar -
Cardiac Risk Assessment in Liver Transplant Candidates: A Survey of National Practice Patterns.
Barman PM, Chadha RM, VanWagner LB, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2022 03 28 3 501-504
-
Radiological and Surgical Treatments of Portal Hypertension.
Research
- Liver transplantation
- Liver diseases
- Nonalcoholic fatty liver disease (NAFLD)
- Cardiac cirrhosis
- Nonalcoholic steatohepatitis (NASH)
Clinical Focus
- Liver Transplantation
- Nonalcoholic fatty liver disease (NAFLD)
- Nonalcoholic steatohepatitis (NASH)
- Cardiac cirrhosis
- Liver Diseases
Results: 1 Locations
Professional Office Building 2
5939 Harry Hines Blvd.Dallas, Texas 75390 214-645-8300 Directions to Professional Office Building 2 Parking Info for Professional Office Building 2
New Patient Appointment Accepting Virtual Visits or 214-645-0595